The continuous glucose monitoring market is expected to grow at a compound annual growth rate of 27.30% over the forecast period to reach a market size of US$31.102 billion in 2026, from US$4.623 billion in 2019.
Continuous glucose monitoring is used to track blood glucose levels, which is also knowns as blood sugar. Doctors and patients usually see and examine glucose levels, which helps them in making more informed and clear decisions, about some of the common activities, such as physical activity, food balance, and medicines. The market is expected to surge in the coming years, due to the increasing rate of diabetes, worldwide. Moreover, the rise of the geriatric population is also expected to play a major role in the overall market growth. Major companies have been investing a significant sum of capital into the development of novel and advanced glucose monitoring solutions, worldwide.
An increasing rate of diabetes
The market is expected to surge and grow during the forecast period, due to the rising rate of diabetes. According to the data given by the World Health Organisation, the total number of persons that have been suffering from diabetes grew from 108 million in 1980 to more than 422 million in the year 2019. Moreover, diabetes has been a key cause of lower limb amputation, stroke, heart attacks, kidney failure, and blindness. In 2019, there had been approx. 1.5 million deaths were related to diabetes. Furthermore, around 2.2 million deaths were due to high blood glucose in 2012. Continuous glucose monitors are widely used by diabetic patients. The monitors help in the measurement of glucose in the fluid, inside a person's body. Dexcom Inc., a key player in real-time continuous glucose monitoring systems, announced in September 2021 that young people with type 1 diabetes would now be covered by the company's G6 continuous glucose monitoring system.
There has been a surge in spending, intending to develop novel and advanced glucose monitoring solutions and monitors. Firms and corporations have been spending a significant sum of their capital on the development of innovative, high-quality, and advanced continuous glucose monitoring devices and solutions.
|The market size value in 2019||US$4.623 billion|
|The market size value in 2026||US$31.102 billion|
|Growth Rate||CAGR of 27.30% from 2019 to 2026|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Application, End-Use Industry, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Dexcom, Inc., Abbott Laboratories, Medtronic Pvt. Ltd., GlySens, Medtrum Technologies, Inc., Tandem Diabetes Care, Senseonics, A. Menarini Diagnostics s.r.l, Roche Diagnostics, Ypsomed AG|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What will be the continuous glucose monitoring market size by 2026?
A1. The continuous glucose monitoring market is expected to reach a market size of US$31.102 billion by 2026.
Q2. What is the size of the continuous glucose monitoring market?
A2. Continuous Glucose Monitoring (CGM) Market was valued at US$4.623 billion in 2019.
Q3. What are the growth prospects for the continuous glucose monitoring market?
A3. The global continuous glucose monitoring market is expected to grow at a CAGR of 27.30% during the forecast period.
Q4. Who are the major players in the continuous glucose monitoring market?
A4. Prominent/major key market players in the continuous glucose monitoring market include Dexcom, Inc., Abbott Laboratories, Medtronic Pvt. Ltd., and GlySens among others.
Q5. What factors are anticipated to drive the continuous glucose monitoring market growth?
A5. The major factor that is expected to drive the continuous glucose monitoring market growth includes a surge in the geriatric population and the high prevalence of the population suffering from diabetes.
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Continuous Glucose Monitoring Market Analysis, By Application
5.2. Diabetes Patients
5.3. Critical Care Patients
6. Continuous Glucose Monitoring Market Analysis, By End-User Industry
6.3. Diagnostic Centers & Clinics
6.4. Home Care
7. Continuous Glucose Monitoring Market Analysis, By Geography
7.2. North America
7.2.1. United States
7.3. South America
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.6. Asia Pacific
7.6.4. South Korea
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. Dexcom Inc.
9.2. Abbott Laboratories
9.3. Medtronic Pvt. Ltd.
9.5. Medtrum Technologies Inc.
9.6. Tandem Diabetes Care
9.8. A. Menarini Diagnostics s.r.l
9.9. Roche Diagnostics
9.10. Ypsomed AG
Medtronic Pvt. Ltd.
Medtrum Technologies Inc.
Tandem Diabetes Care
A. Menarini Diagnostics s.r.l
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.